Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0001615774-17-001879
Filing Date
2017-04-27
Accepted
2017-04-27 15:56:49
Documents
1
Effectiveness Date
2017-04-27
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 9427
  Complete submission text file 0001615774-17-001879.txt   10663
Mailing Address 2511 N LOOP 1604 W SUITE 204 SAN ANTONIO TX 78258
Business Address 2511 N LOOP 1604 W SUITE 204 SAN ANTONIO TX 78258 (210) 479-8112
Inspyr Therapeutics, Inc. (Filer) CIK: 0001421204 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D/A | Act: 33 | File No.: 021-283930 | Film No.: 17788908
SIC: 2834 Pharmaceutical Preparations